Beckman Coulter, Inc.
 

Resource Center

 
 
 
 
 
 
 
   
   
 
 

Automation of the MessageAmp* II-96 aRNA Amplification System from Ambion* Using the Biomek® 3000 Laboratory Automation Workstation from Beckman Coulter

Printer Friendly

Matthew Cu and Zhu Zhu, Beckman Coulter, Inc.; and Roy C. Willis, Ambion, Inc.

Introduction

Manual target preparation for gene expression analysis is inherently laborious, time consuming and error prone. To overcome these conditions, we developed automated target preparation methods, cDNA Synthesis and in vitro Transcription, on the Biomek 3000 Laboratory Automation Workstation using the MessageAmp* II-96 aRNA Amplification Kit from Ambion*. These automated high-throughput methods are designed specifically to address problems such as variability, consistency and reproducibility associated with sample preparation. Both methods can be used to process any desired number of samples up to 96 in multiples of eight, with the start and stop on desired columns. The cDNA Synthesis method synthesizes first-strand cDNA using ArrayScript*, a reverse transcriptase (RT) engineered to produce higher yields of first-strand cDNA than wild type enzymes. ArrayScript catalyzes the synthesis of virtually full-length cDNA, ensuring superior microarray results. The cDNA undergoes second-strand synthesis, then purification to remove salts, RNA, primers and enzymes. The purified cDNA is subsequently used for in vitro transcription (IVT). To maximize the antisense RNA (aRNA) yield from the IVT reaction, Ambion uses its proprietary MEGAscript* IVT technology to generate hundreds to thousands of aRNA copies from each mRNA in a sample. The aRNA is purified using Ambion's MagMAX magnetic bead-based RNA purification to remove any unincorporated nucleotides, enzymes and salts from the aRNA prep. Quantification of aRNA is done off-line using a Molecular Devices SPECTRAmax PLUS 384 Microplate Reader.

For this study, 1 µg input amount of HeLa total RNA was used for three columns each of biotin-labeled and unlabeled aRNA; all samples were prepared using 14-hour IVT reactions. Recovery of aRNA was highly consistent, with average yields of 123.1 µg and 161.2 µg for labeled and unlabeled aRNA, respectively.

Materials

Biomek 3000 and Accessories:

Part No. Description
986120 Biomek 3000 Laboratory Automation Workstation
391900 MP20 Multi-Tip Pipette Tool: Capacity 1-20mL
986146 MP200 Multi-Tip Pipette Tool: Capacity 5-200mL
A09053 Gripper Tool Kit
391910 Tip Rack Holder
987199 Worksurface Spill Tray
987263 Right Side Module
987264 Left Side Module
609078 Side Module Spill Tray
609120 Labware Holder, Gray
380560 DPC Shaker
609042 P20 Tip, Sterile
372655 P250 Tip, Sterile
372795 Frame for Polypropylene Reservoirs
372790 Quarter Reservoir
372788 Quarter Reservoir, Divided by Length
372786 Half Reservoir
609801 CEQ Sample Microtiter Plate

Consumables:

Source Part No. Description
Ambion, Inc. 1819 MessageAmp II-96 aRNA Amplification Kit-100 reactions
Ambion, Inc. 10050 96-Well Magnetic-Ring Stand
E and K Scientific EK-20101 96-Well Plate, Round Bottom Clear
Evergreen Scientific P/N 222-8032-01R 96-Well Plate, Round Bottom w/Lids
Sigma Aldrich E7 023-500 mL Ethanol, absolute, 200 proof 
Ambion, Inc.   Biotin-11-UTP (75mM)

Methods

MessageAmp II-96 aRNA Amplification Protocol



Figure 1. Flow diagram showing the MessageAmp II-96 aRNA Amplification Procedure.

Biomek 3000 cDNA Synthesis Instrument Setup


Figure 2. Deck layout for cDNA Synthesis method. The DPC shaker is integrated on the left side of the deck (MM1 and MM2). 

Biomek 3000 IVT Setup Instrument Setup


Figure 3. Deck layout for IVT Setup method. 

Biomek 3000 IVT Cleanup Instrument Setup


Figure 4. Deck layout for IVT Cleanup method. 

Results

µg Biotin Labeled aRNA µg Unlabeled aRNA
125.99 130.90 124.18 169.11 184.94 187.99
126.31 122.04 86.87 148.22 171.19 159.97
146.26 129.61 117.91 154.30 178.97 153.49
161.71 139.24 99.44 147.42 142.29 159.58
116.87 159.75 111.36 154.86 147.17 148.48
150.45 199.01 91.65 114.15 161.34 161.26
119.14 117.49 106.39 155.25 160.63 156.72
118.23 78.11 108.30 201.42 176.80 173.81
average 124.47   average 161.22  
std dev 26.27   std dev 17.79  
%CV 21%   %CV 11%  

Figure 5. RNA Amplification using MessageAmp II-96 aRNA Amplification Kit on Biomek 3000. Forty-eight replicates of 1.0 µg HeLa total RNA inputs were amplified with or without biotin according to the MessageAmp II-96 protocol on the Biomek 3000 using a 14-hour IVT reaction incubation time. Following aRNA cleanup, yield was assessed by measuring UV absorbance at 260 nm. Average yields of 123.1 µg and 161.2 µg for labeled and unlabeled aRNA, respectively.

A. 
Figure 6A. Bioanalyzer Electropherogram of labeled amplified cRNA from 1.0 µg input HeLa total RNA.

B. 
Figure 6B. Bioanalyzer Electropherogram of unlabeled amplified cRNA from 1.0 µg input HeLa total RNA.

Figure 6. Bioanalyzer Electropherograms of labeled (A) and unlabeled (B) amplified cRNA from 1.0 µg input HeLa total RNA. The mRNA Smear Assay reveals the size distribution of 250 to 5500 nucleotides with a peak centered at 1400 nucleotides. Similar aRNA profiles were observed for labeled and unlabeled aRNA.

Discussion and Conclusions

We have demonstrated the automation of the MessageAmp II-96 aRNA Amplification Kit on the Biomek 3000 Laboratory Automation Workstation. This automated method produced consistent and reproducible aRNA yield with minimal user intervention. Ambion recommends an IVT reaction time of 4 – 14 hours. For the data presented here, we used a 14-hour IVT processing time for the amplification of cDNA from 1 mg input HeLa total RNA. We obtained high-yield and high-quality amplified aRNA from this automated method. The size distribution of the aRNA ranged from 250 to 5,500 nucleotides with a midpoint size of 1,400 nucleotides. We've consistently obtained these results, ensuring successful microarray analysis.

* All trademarks are the property of their respective owners.

For Research Use Only; not for use in diagnostic procedures.

 
 
Home | Products | Customer Support | Resource Center
Employment | Our Company | Contact Us | Site Map
 Privacy©1998 - 2008 Beckman Coulter, Inc.